GlassScriptPhysician profile
Donald C Beringer
NPI 1356300875
$13,457.44
in general payments reported to CMS, 2019-2025
28 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,425 · 2020: $102 · 2021: $409 · 2022: $5,955 · 2023: $439 · 2024: $1,676 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,868 · Food and Beverage: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,868.07 |
| Food and Beverage | $1,698.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $5,557.13 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,650.99 | 2019-2021 | |
| Medacta USA, INC. | $1,527.11 | 2021-2024 | |
| Stryker Corporation | $1,350.01 | 2019-2025 | Mako, Aequalis Perform, Gamma |
| Avanos Medical | $1,307.54 | 2019-2022 | |
| Onkos Surgical, INC. | $296.86 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $275.32 | 2019-2022 | |
| Depuy Synthes Sales INC. | $182.08 | 2019-2023 | Orthovisc |
| Smith+Nephew, INC. | $163.63 | 2025 | Real Intelligence, Pico 7, Pico 14 |
| Ge Healthcare | $146.43 | 2023 | |
| Intrinsic Therapeutics | $126.05 | 2025 | Barricaid Acd (Annular Closure Device) |
| Think Surgical, INC. | $122.33 | 2024 | |
| Ferring Pharmaceuticals INC. | $117.35 | 2022-2025 | Euflexxa |
| Aadi Bioscience, INC. | $116.18 | 2024 | Fyarro |
| Amgen INC. | $90.82 | 2024-2025 | Krystexxa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $66.90 | 2023-2024 | Arista Ah Flexitip |
| Innovation Technologies INC | $63.37 | 2023 | Irrisept |
| Kyocera Medical Technologies, INC. | $54.40 | 2023-2024 | |
| Angiodynamics, INC. | $51.34 | 2024-2025 | Nanoknife |
| Pacira Therapeutics, INC. | $34.51 | 2019 | |
| Ethicon US, LLC | $27.84 | 2022 | |
| Axogen | $27.40 | 2022 | |
| Convatec INC. | $25.04 | 2020 | |
| Galvanize Therapeutics, INC | $19.28 | 2024 | Aliya System |
| Acera Surgical, INC. | $16.63 | 2023 | Restrata Wound Matrix |
| United Orthopedics LLC | $15.46 | 2024 | |
| Illuminoss Medical, INC. | $14.68 | 2022 | |
| Orthofix Medical, INC. | $10.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Beringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.